Drug Delivery

Drug delivery is the method in which a pharmaceutical compound is administered to promote a therapeutic effect. Drug delivery routes can include oral, transdermal, nasal, and sublingual application and can directly impact a drugs efficacy. In this drug delivery content hub, you can discover editorial coverage of the latest research and industry trends impacting drug delivery and novel drug discovery.

  • An Interview with Sabrina Graf- COO, Tenthpin

    I think the main developments have been the automation of complex processes, the improvement of data accuracy, and ensuring adherence to regulatory standards (GxP). This is what we hear from the top and leading global pharma companies as well when working with them. Vast datasets can be monitored in real-time, promptly identifying deviations or ... read more

  • An Interview with Scott Bone – Head of Formulation and Process Science, Bend Bioscience

    The industry must adopt a science-driven, data-informed development strategy. A foundational understanding of the active pharmaceutical ingredient’s (API) physicochemical properties, the matrix characteristics, and the drug’s pharmacokinetic (PK) and pharmacodynamic (PD) profiles is essential. Leveraging these insights early in development ... read more

  • Transforming Substance Data for Faster Submissions and Improved Drug Safety

    When people want to understand a word, they turn to a dictionary for its widely accepted definition, history, and relation to other words. In the scientific field, the need to access standardized definitions is no different, and that’s exactly why the Global Substance Registration System (GSRS) was developed. read more
Page

  • Whitepaper: Key Considerations for Extracting Proteins from Recombinant Host Cells

    In the biopharmaceutical industry, quality is pivotal. For a final product to meet quality standards, quality must be built into the production process. Biopharmaceuticals, however, are made from biologically sourced materials, which are inherently variable. read more

  • eBook: Glass Related Recalls in Pharma

    Typically, drug recalls fall into two categories: recalls issued for the cracking or breaking of glass vials and recalls issued for the presence of particulates being detected in the drug solution. read more

  • Whitepaper: Purification Strategies for Recombinant Therapeutic Proteins

    Many biopharmaceuticals are recombinant proteins obtained by biotechnological processes. In various steps of the pharmaceutical value chain, from drug discovery, to development and manufacturing, to bioprocessing, these proteins must be extracted from their complex biological sources, typically microorganisms or genetically ... read more

  • Whitepaper: Global regulators’ FAQs on CMC in IND/BLA filing

    Mammalian cell cultures used in the manufacturing of therapeutics must be tested to ensure lack of mycoplasmal contamination. Previously, the only test for mycoplasma accepted by regulatory agencies was a culture-based test such as the test detailed in USP <63>. Currently, regulatory agencies globally accept nucleic acid testing ... read more

  • Whitepaper: How to Develop an Efficient Drug Formulation Process

    Developing an efficient drug formulation development process requires expertise. Ascendia Pharmaceuticals, a leading specialty CDMO, has been recognized as a Partner of Choice by many drug companies because they have solved complex formulations for nearly a decade. Ascendia’s white paper details how to implement a drug discovery... read more
Page

Webinars

  • <<
  • >>